The development of subunit antigen delivery formulations has become an important research endeavor, especially in cases where a whole cell vaccine approach has significant biosafety issues. Particle-based systems have shown particular efficacy due to their inherent immunogenicity. In some cases, fabrication techniques can lead to changes in the redox states of encapsulated protein antigens. By employing a uniform, wellcharacterized, single-component system, it is possible to elucidate how the molecular details of particle-based protein antigens affect their induced immune responses. Using mesoporous silica-templated, amide bond-stabilized ovalbumin particles, three types of particles were fabricated from native, reduced, and oxidized ovalbumin, resulting in particles with different physicochemical properties and immunogenicity. Phagocytosis, transcription factor activation, and cytokine secretion by a mouse macrophage cell line did not reveal significant differences between the three types of particles. Oxidation of the ovalbumin, however, was shown to inhibit the intracellular degradation of the particles compared with native and reduced ovalbumin particles. Slow intracellular degradation of the oxidized particles was correlated with inefficient antigen presentation and insignificant levels of T cell priming and antibody production in vivo. In contrast, particles fabricated from native and reduced ovalbumin were rapidly degraded after internalization by macrophages in vitro and resulted in significant T cell and B cell immune responses in vivo. Taken together, the current study demonstrates how the redox state of a protein antigen in a particulate formulation significantly impacts the immunogenicity of the particle vaccine.
processes result in a change in redox state. In addition, many thiol-reactive molecules (e.g., tripeptide glutathione (GSH) and reactive oxygen species (ROS)) are present at various cellular environments. For example, GSH is abundant in cytoplasm, ROS can be found in lysosomes and mitochondria, and many proteins containing thiols are expressed on cell surfaces. These thiols have been shown to play important roles in immune functions, such as T cell proliferation, and are tightly regulated during antigen presentation. 30 However, it remains unclear how the redox states of proteins in particlebased antigen formulations impacts their interactions with cellular thiol-reactive molecules and the subsequent immune responses. As this information is key for rationally designing particle-based subunit antigen delivery systems, studies that address these questions are important in the field of vaccine delivery.
Well-defined and uniform particles can be used to evaluate specific parameters governing immune responses. Mesoporous silica (MS)-mediated assembly is a facile approach for fabricating particle systems with precise control over particle physicochemical properties, as well as cargo loading and release, 7, [31] [32] [33] while ovalbumin (OVA) is a well-studied model antigen. To take advantage of these two aspects, herein we design a novel MS template-assembled pure OVA particle formulation stabilized through amide bonds, and investigate the immunological influence of protein redox state.
OVA contains four free thiols and one intrachain disulfide bond in its native structure. 34 By fabricating particles from native, reduced, and oxidized OVA (n-OVA, r-OVA, o-OVA particles, respectively), three types of particles with different structural properties were fabricated and the redox states were confirmed by measuring the degree of free thiol reactivity. We examined the interactions between the particles and innate immune cells by measuring phagocytosis, intracellular degradation, NFκB and AP-1 transcription factor activation, and cytokine secretion by a murine macrophage cell line, RAW 264.7 (ATCC TIB-71) (RAW). Although RAW cells were able to bind and rapidly phagocytose all particles to a similar extent, resulting in activation of transcription factors and secretion of cytokines, the n-OVA and r-OVA particles were degraded more rapidly than o-OVA particles, suggesting different antigen processing occurred. Next, we evaluated the efficiency of immunogenic OVA epitope presentation by splenocyte APCs ex vivo, and the capacity for priming T cells and generating immunoglobulin G (IgG) upon immunization in vivo. Our results show that slow intracellular degradability of oxidized OVA particles is correlated with inefficient OVA epitope presentation and immunogenicity ex vivo and in vivo. In contrast, particles fabricated from native and reduced OVA were found to elicit superior T cell proliferative responses than free OVA and induce the highest levels of cytokine-producing CD4 T cells. In addition, both n-OVA and r-OVA particles were shown to stimulate the highest antibody titers after immunization compared with o-OVA particles. Combined, our results demonstrate that the different redox states of protein antigens leads to the generation of protein particles with variable physicochemical properties, including size, antigen loading, and protein density. These properties (in particular, particle density) have been shown to profoundly impact the antigen processing, giving rise to distinctively different immunogenicity of particles. Given the high likelihood that many currently-used particle fabrication techniques result in changes to redox state and structure of protein antigens, this information is valuable knowledge for the development of effective and safe protein vaccines.
6

RESULTS AND DISCUSSION
Fabrication of Ovalbumin Particles of Different Redox States. Using MS templating and amide crosslinking, three types of pure ovalbumin particles with various redox states were fabricated (Figure 1a ). Amine-functionalized MS templates (average diameter of 1 μm) were first loaded with native OVA (M W 46 000) at pH 6, where OVA is negatively charged (isoelectric point=4.6). Reduced and oxidized OVA particles were generated by treating the OVA-loaded MS particles with a reducing agent (DTT) or an oxidizing agent (chloramine-T). Then, particles containing either native, reduced, or oxidized OVA were stabilized through amide bond crosslinking using 4-(4,6-dimethothy-1,3,5-triazin-2-yl)-4methylmorpholinium chloride (DMTMM), a nontoxic coupling reagent that can be completely removed from the post-reaction mixture. 35 Stable, freestanding, singlecomponent OVA particles were obtained after template removal. TEM images ( Figure   1b -d) were used to measure particle size (Table 1) and visualize particle morphology.
Images revealed distinct size and morphological differences between the particles as a result of oxidation and reduction of the protein. Oxidation resulted in smaller particles of about 460 ± 70 nm, approximately half the size of n-OVA and r-OVA particles, which were 930 ± 160 and 810 ± 140 nm, respectively. Further, the o-OVA particles showed a high contrast compared with n-OVA and r-OVA particles in TEM images, suggesting a high protein density. Oxidation of proteins leads to alterations in protein structure via the formation of new disulfide bonds. 36 The addition of new disulfide bonds has been shown to enhance the structural stability of free proteins. 15 Within the particle, the formation of new disulfide bonds also seems to enhance the structural stability of the protein network, 7 which explains the shrinkage of the particles upon template removal. The r-OVA particles appeared to be slightly smaller with a higher contrast and more uniform density compared with n-OVA particles. Reduction of OVA with DTT has been shown to successfully cleave the native intrachain disulfide formed between Cys 73 and Cys 120 , exposing domains that were previously hidden in the native conformation. 37 We assume that this conformational alteration leads to changes in the intra-and inter-protein attractive forces (e.g., covalent, electrostatic, van der Waals), resulting in size and morphological changes in the r-OVA particles. Based on the total number, mass, and size of the particles, the average OVA loading capacity and OVA density were calculated for each particle (Table 1) . Results showed similar loading capacities across all particles leading to variations in OVA density due to particle size, confirming that TEM data accurately represents protein density. While r-OVA and n-OVA particles had a similar density, o-OVA particles had a higher average density that was more than 12-and 7-fold higher than n-OVA and r-OVA particles, respectively. These results suggest that variations in protein redox states influence the structure of the protein network even if the same crosslinking strategy is used (i.e., amide crosslinking).
To confirm that the exposure of the OVA proteins in the MS templates to oxidizing and reducing conditions led to alteration of the native free thiols and disulfide bonds, free thiol groups in each particle were qualitatively determined by measuring their reactivity towards a maleimide-conjugated fluorescent dye (Alexa Fluor 488-maleimide) using flow cytometry. To verify the specificity of the reaction, n-OVA and r-OVA particles were also pretreated with excess 2,2'-dinitro-5,5'-dithiobenzoic acid (DTNB, Ellman's reagent) for 6 h to block the free thiols and inhibit their reactivity toward the maleimide.
DTNB-treated and untreated particles were incubated with excess fluorescent label, washed extensively, and the mean fluorescence intensity (MFI) was measured using flow cytometry (Figure 2a ). Results showed that the MFI of o-OVA and r-OVA particles was shifted to lower and higher values compared with n-OVA particles, respectively.
Additionally, pretreatment with DTNB resulted in MFI values similar to those observed for o-OVA particles, confirming the specificity of the thiol-maleimide reaction. To correct for differences in protein content per particle, MFI per ng of OVA was also calculated based on OVA loading capacity ( Figure 2b ). As expected, the r-OVA particles resulted in the highest MFI/ng, followed by n-OVA and o-OVA particles, respectively.
These data confirm that treatment of the OVA with reducing and oxidizing agents alters the native thiols and disulfide bonds within OVA proteins, leading to particles with different redox states. Additionally, the zeta potentials of the particles were not altered as a result of changing the protein redox state: they were determined to be approximately -20 mV in 10 mM Dulbecco's Phosphate Buffered Saline (DPBS) for all three particles ( showed a cumulative increase in zeta potential where all particles had a zeta potential of -17 mV. The results suggest that protein adsorption neutralizes the particle surface charge. cells of the innate immune system that have specifically evolved to internalize particulate material through a specialized form of endocytosis called phagocytosis. 38 Phagocytosis is a necessary process for eliciting robust immune responses to particulate material whereby antigen processing and presentation pathways are accessed via the phagosome, 39 which has a characteristically low pH of approximately 5. 40 Hence, pH-sensitive fluorophores have been employed to evaluate the acidification of particle-containing phagosomes. 41 Using particles labeled with both pH-independent and pH-dependent fluorophores, the difference in associated (both surface bound and internalized) and phagocytosed particles could be determined by detecting the signal from the respective labels using flow cytometry and fluorescence deconvolution microscopy. The fluorescence of Alexa Fluor 633 (AF633) is insensitive to a wide pH range, including physiological and phagosomal pH, making it well suited for detecting both adhered and internalized particles. pHrodo-Red (Life Sciences, Pty Ltd, NSW, Australia) is a pH-sensitive fluorochrome that has been used to examine phagocytosis. 42 The fluorescence of pHrodo-Red significantly increases in acidic conditions, such as those found within the macrophage phagosome, allowing the determination of phagocytosed particles.
The percentage of cells with either associated (i.e., positive AF633 signal) or phagocytosed (i.e., positive pHrodo-Red signal) particles were measured after incubating RAW cells with particles at 37 °C and 5% CO 2 for 1, 3, 6, and 24 h time intervals. At 1, Intracellular degradation of the OVA particles was determined by visualization of RAW cells with internalized particles using fluorescence deconvolution microscopy. In this experiment, fluorescently labeled particles were incubated with RAW cells for 1, 3, and 6 h time intervals and unassociated particles were removed by extensive washing with DPBS prior to imaging using deconvolution microscopy. Illustrated by the first appearance of these fluorescent particle fragments, n-OVA and r-OVA particles showed initial degradation at 3 h incubation and an increased occurrence of these fragments after To further delineate the role of protein density and disulfide bonding in intracellular degradation, o-OVA particles were exposed to DTT for 1 h at 37 °C to reduce the disulfide bonds. To verify the reduction of disulfide bonds, particles were labeled with a maleimide-conjugated fluorophore and the MFI was measured ( Figure S1 ). A similar experiment comparing the intracellular degradation of o-OVA and reduced o-OVA particles in RAW cells showed no apparent differences at the time points examined ( Figure S2 ).
Intracellular degradation of proteins is highly dependent on the accessibility of enzymatic cleavage sites. For enzymes to gain access to various sites within the protein, the 3D structure must be unfolded. 47 Structural changes in the particles induced by oxidation and reduction were likely the result of alterations in covalent and noncovalent interactions. Oxidation increases the structural stability of the protein particle matrix, evidenced by the increase of disulfide bonds and high OVA density. Structural constraints induced by disulfide bonds, 15, 48, 49 chemical crosslinks, 16 and noncovalent interactions 13 have been shown to reduce the susceptibility of free soluble proteins to proteolytic digestion, which is in good agreement with the current findings. In the particle formulation, oxidation and reduction changed the disulfide bonding within the particles, which caused differences in their physical properties (i.e., protein density). Reduction of disulfide bonds facilitates protein unfolding and has been shown to increase the susceptibility of free cysteine-containing proteins to enzymatic degradation. 48, 49 Particle density, however, determines enzymatic permeability throughout the protein matrix. Our data have shown that n-OVA and r-OVA particles with similar particle density but different number of thiols exhibited similar intracellular degradation. Similarly, the reduced o-OVA particles showed consistently prolonged intracellular degradation profile compared with o-OVA. Taken together, these results suggest that OVA particle density plays a major role in controlling the intracellular degradation kinetics. T Cell Activation. The immunogenicity of the particles was investigated through a series of assays that measure the induction of OVA-specific T cell responses. The presentation of immunogenic OVA epitopes was investigated by stimulating OVAprimed T cells with APCs and particles ex vivo and measuring their proliferation and cytokine secretion. Mice (C57BL/6) were initially immunized with free OVA emulsified with IFA, a strong adjuvant mixture that results in proliferation of OVA-specific T cells.
One week following immunization, the draining lymph nodes were harvested and OVAprimed T cells were isolated using anti-CD90.2 magnetic bead sorting. Syngeneic APCs (mytomycin C-treated splenocytes) from naive mice were pre-incubated for 1 h prior to addition of OVA-primed T cells with serial dilutions of either free soluble OVA, n-OVA, o-OVA or r-OVA particles at equivalent total protein levels. The extent of antigenspecific T cell proliferation was then determined following 4 days of incubation by the incorporation of 3 H-thymidine. In comparison to the equivalent free soluble OVA, a significantly enhanced T cell proliferative response was found at 8 different antigen doses for r-OVA particles, 4 different antigen doses for n-OVA particles, and 2 doses for o-OVA particles, respectively (Figure 7a , Table S1 for statistical analysis, two-way ANOVA analysis). This suggests an increase in potency of immune responses induced by particulate antigen carriers compared with free soluble antigen, which is in agreement with other studies. 6, 25, 50, 51 It is also noted that r-OVA showed significantly enhanced T cell proliferation compared to n-OVA or o-OVA particles at a certain dose, although for most of the doses no significant differences were found between the three types of particles, (Figure 7a , Table S1 ).
To further investigate the functions of the stimulated T cells, an ELISPOT assay was used to determine T cell differentiation (T helper 1 (Th1) versus T helper 2 (Th2)) by measuring the number of T cells producing either IFN-γ or IL-4 cytokines, respectively. r-OVA particles induced significantly more IL-4-secreting T cells than n-OVA (p < 0.05) and o-OVA (p < 0.001) particles. Similar trends were also observed in IFN-γ-producing T cells (Figure 7b , Table S2 for statistical analysis, one-way ANOVA analysis). Overall, the results indicated a Th1-polarized proinflammatory response where all OVA particles stimulated a higher number of IFN-γ-producing T cells compared with IL-4 ( Figure 7b ).
Studies have indicated that processes leading to antigen presentation occur quickly after internalization. 52 A rapid degradation kinetics of a both free proteins 15,17 and antigen particle carriers 53 is favorable for efficient antigen presentation. In good agreement, our data also demonstrate a correlation between intracellular particle degradation and OVAspecific immunogenicity. A slow intracellular degradation of o-OVA particles results in a significant reduction of OVA epitope presentation by APCs in comparison to r-OVA and n-OVA particles. Moreover, the difference between r-OVA and n-OVA suggests that a reducing redox state can further facilitate the OVA epitope presentation to T cells, although their intracellular degradation based on the morphological changes in vitro did not exhibit significant variations. 
IFN-γ-(gray bars) producing T cells per million T cells when stimulated with splenocyte
APCs and 2.5 μg of either OVA particles (n-OVA, r-OVA, o-OVA) or free soluble OVA at 37 °C, 5% CO 2 ex vivo for 3 days measured using an ELISPOT assay. Statistical analyses are shown in Table S1 and S2.
The immunogenicity in vivo was investigated by measuring OVA-specific T cell responses following immunization with the particles. The efficiency of OVA-specific T cell priming in vivo was determined by measuring T cell differentiation in response to soluble OVA stimulation ex vivo using an ELISPOT assay described above. T cells from mice immunized with a 1:1 oil-in-water emulsion of PBS and IFA were used as negative controls ( Figure S3 ), which, as expected, failed to exhibit any OVA-specific T cell response. Stimulation of T cells obtained from mice immunized with r-OVA particles resulted in significantly more IL-4-and IFN-γ-producing T cells compared with the blank samples (i.e., unstimulated). n-OVA particle-primed T cells also showed significant increases in IFN-γ-secreting T cells in the presence of free OVA. This suggests that r-OVA and n-OVA particles are capable of priming T cells to specifically respond to ovalbumin when injected in vivo. However, T cells from o-OVA-immunized mice did not respond to antigen stimulation, indicating that the particles did not efficiently prime OVA-specific T cells in vivo. Given the correlation between the current results, intracellular degradation ( Figure 5 ), and OVA epitope presentation (Figure 7) , it is likely that antigen-specific T cell priming in vivo is directly affected by the efficiency of intracellular degradation and OVA epitope presentation by APCs. OVA-specific IgG present in the serum following a primary and secondary immunization. In the experiment, mice were given a primary intraperitoneal immunization of n-OVA, r-OVA, and o-OVA particles and a booster subcutaneous immunization two weeks later. Naive mice and mice immunized with OVA and IFA were used as negative and positive controls, respectively. The results showed that the sera obtained from mice immunized with n-OVA and r-OVA particles contained statistically similar levels of IgG that were significantly higher than sera from mice immunized with o-OVA particles (p < 0.001) (Table S3 for Table S3 .
CONCLUSIONS
The current study presents an analysis of the physicochemical and immunological consequences of oxidation and reduction of a protein antigen (i.e., OVA) formulated within a mesoporous silica-templated, amide cross-linked particle system. Our data show that redox modifications affect both the physicochemical properties (i.e., size, morphology, density, redox state) and the immunogenic performance of the particles. Our results show that despite the redox-induced physicochemical differences among the particles, innate immunogenicity is not largely affected (i.e., phagocytosis, NFκB and AP-1 transcription factor activation, cytokine secretion). However, oxidation is shown to inhibit the rate of intracellular degradation of the particles compared with those fabricated from native and reduced protein, most likely due to increased protein density. The slow intracellular degradation of the oxidized protein particles is correlated with inefficient epitope presentation and insignificant levels of antibody secretion in vivo; therefore suggesting the direct impact of antigen degradability on adaptive immune responses.
Taken together, the current study demonstrates how the redox state of protein antigens in particle-based formulations can affect antigen intracellular processing, which is a strong prerequisite for antigen presentation and subsequent adaptive immune responses. Given that protein antigens are typically highly susceptibility to structural alteration during chemical processing (e.g., reduction and oxidation), our understanding of these changes and their associated immunological impacts is important for optimizing particle formulations for protein antigen delivery. week later. Single cell suspensions were prepared using a gentleMACS dissociator (Miltenyl Biotec). T cells were isolated using magnetic-activated cell sorting using an autoMACS cell sorter (Miltenyl Biotec).
METHODS
Materials
T Cell Proliferation Assay. Suspensions of 3 x 10 5 APCs and 3 x 10 5 T cells were cultured. Particles were pulsed with serial dilutions of particles or free OVA ranging from 50 -0.39 μg mL -1 . 3 H-thymidine was added after ~70 h of incubation at 37 °C, 5% CO 2 .
ELISPOT Assay. Suspensions of 3 x 10 5 APCs and 3 x 10 5 T cells were cultured onto IL-4 and IFN-γ ELISPOT plates (Millipore) in triplicate and restimulated with 2.5 μg of either OVA particles or free OVA. ELISPOT plates were developed according to the manufacturers' instructions after ~70 h of incubation at 37 °C, 5% CO 2 . Data are representative for three independent experiments.
Immunization for Antibody Study. C57/Bl6 mice 6-8 weeks old were immunized intraperitoneally with 25 μL of either 1 mg mL -1 OVA particles or a 1:1 water-in-oil emulsion of 1 mg mL -1 OVA protein in DPBS and IFA. After 21 days the mice were given a booster subcutaneously injection with the same antigens and then bled 10 days later. The collected sera was individually stored at -20 °C.
ELISA. Enzyme-linked immunosorbent assays (ELISAs) were performed on sera from five mice in each group. 
